A 2026 randomized placebo-controlled trial just found that a daily yeast-derived nucleotide supplement significantly improved memory and cognitive test scores in seniors with mild cognitive impairment — in just 6 months, with zero reported side effects.
Video Timestamps
0:00 – Introduction and Synopsis of the Amazing Study
0:18 – Randomized Placebo Control Trial: Participants and Methodology
0:46 – Remarkable Gains in Montreal Cognitive Assessment (MoCA) Scores
1:13 – The 3-Month Turning Point and Membrane Phospholipid Pools
1:29 – Supplement Details: Yeast Extract Dosage and Gastric Resistance
2:15 – Analogies: The “Oil Light” for the Brain and Plasticity
2:58 – Quality of Life: How Participants Felt (Baker’s Yeast vs. Dairy Yeast)
4:05 – Estimated Cost and Accessibility of Common Yeast Extracts
4:21 – The “Neurobiological Villain”: Aging Neurons and Fluidity
4:42 – Deep Dive into the Study Text and Mechanisms (Synaptogenesis)
6:14 – Results: Returning to Normal Cognition after 180 Days
7:28 – Secondary Outcomes: Mental vs. Physical Quality of Life
8:10 – The Nucleotide Cascade: Why it Takes Time to See Results
9:15 – Synergy and Unexpected Benefits (Microbiome and Immunity)
10:16 – Practitioner’s Brief: Safety, Exclusions, and Study Power
11:55 – Interrogation Matrix: Analysis of Changes and Grouping
13:06 – Conclusion: A Simple Solution for Humanity
Here’s what the science actually says.
📰 Study: Ullah et al., Nutrients 2026 | https://doi.org/10.3390/nu18121869
🔬 WHAT THE STUDY FOUND
72 older adults (ages 60–85) with mild cognitive impairment (MCI) were split into three groups
for 180 days:
• Group 1: Kluyveromyces fragilis yeast extract (RiboDIET®)
• Group 2: Saccharomyces cerevisiae yeast extract (RiboMIX SC)
• Group 3: Placebo
On the Montreal Cognitive Assessment (MoCA, scored out of 30):
✅ K. fragilis group: +4.42 points (crossed into normal cognition range)
✅ S. cerevisiae group: +3.92 points (crossed into normal cognition range)
❌ Placebo group: +0.58 points (no significant change)
On the Mini-Mental State Examination (MMSE):
✅ K. fragilis group: +1.62 points
✅ S. cerevisiae group: +3.11 points
❌ Placebo group: +0.25 points
Mental quality of life (SF-12 Mental Component Score):
✅ K. fragilis: +7.50 points
✅ S. cerevisiae: +9.16 points
❌ Placebo: no significant change
No adverse events were reported in either supplement group.
━━━━━━━━━━━━━━━━━━━━━
⚠️ IMPORTANT CAVEATS
This is a single-center, 72-person pilot trial. The results are encouraging but NOT yet definitive
clinical evidence. Larger multicenter trials are needed before firm recommendations can be made.
This video is for educational purposes — always consult your physician before starting any supplement.
━━━━━━━━━━━━━━━━━━━━━
🧬 WHY NUCLEOTIDES?
Nucleotides are the building blocks of DNA and RNA. When derived from yeast, they appear to:
• Support brain membrane phospholipid synthesis
• Promote synaptogenesis (new synaptic connections)
• Reduce neuroinflammation
• Positively influence the gut-brain axis
━━━━━━━━━━━━━━━━━━━━━
🔔 Subscribe for weekly breakdowns of peer-reviewed medical research — translated for real people.
📌 Related videos:
• Choline Supplementation and Alzheimer’s Prevention → https://www.youtube.com/watch?v=KNOXwt4h7ew
• DHA Dramatically Improves IQ, Cognition & Hippocampus Volume in Older Adults → https://www.youtube.com/watch?v=l7eQMHUe_Oo
• Cognitive Decline Reversed 30 Years in 6 Weeks → https://www.youtube.com/watch?v=r82lK9UQFNg
#BrainHealth #CognitiveDecline #MildCognitiveImpairment #Dementia #Nutraceuticals #MemoryLoss #NutritionScience #ClinicalTrial #AlzheimersResearch #VHFILM
Ullah H, Cordara M, Morone MV, Piccinocchi R, De Lellis LF, Cerqua A, Baldi A, Sacchi R, Piccinocchi G, Di Minno A, et al. Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial. Nutrients. 2026; 18(12):1869. https://doi.org/10.3390/nu18121869